|
|
|
Jim Dreyfous co-founded UV Partners in 1986 and has been a Managing Director since its formation. Mr. Dreyfous personifies the UV Partners culture and approach; he is active with business founders and directors, experienced in building and developing management teams, and adept at accessing strategic relationships to help companies to attract management expertise and capital at every stage of a company's growth. He was active in the investment and/or served as a board member of Anesta (IPO), CardioPulmonics (IPO), Iomed (IPO), Sonus (IPO), Sonic Innovations (IPO), Clyde Digital (acquired by Axent), VaporFab (acquired by INCO), and Knowlix (acquired by Peregrine Systems).
|
|
More...
|
|
|
Adapx CEO and Chairman of the Board, Ken Schneider has more than 20 years of senior level P&L accountability and management experience in product management, marketing, business development and strategic planning, and product engineering delivery, for a wide range of venture backed technology companies and industry sectors.
|
|
More...
|
|
|
Dr. Philip R. Cohen, Adapx |
|
Dr. Philip Cohen was most recently professor and co-director of the Center for Human-Computer Communication in the Department of Computer Science and Engineering at the Oregon Health and Science University. Cohen founded NIS in 1999 as a spin-off of the Oregon Graduate Institute (which was later renamed the Oregon Health and Science University).
|
|
More...
|
|
|
Mr. Maloney is a Co-founder of Paladin and a Managing Director of Paladin. He serves on the Paladin Capital Group Investment Committee of the Paladin Fund. He also serves as the firm's Chief Compliance Officer and Chief Marketing Officer. He is responsible for Paladin's new business development, client servicing, fundraising and compliance related activities. Prior
|
|
More...
|
|
|
Dr. Rick LeFaivre, OVP Venture Partners |
|
Dr. Rick LeFaivre joined OVP Venture Partners in 2004 and focuses on technology-based investments in information technology and digital biology. He currently serves as a board member to Adapx, Gainspan Inc., GenoLogics Life Sciences, M2E Power, Plectix BioSystems and Vantos, and is a member of Ambric's Technology Advisory Board.
|
|
More...
|
|
|
Chad Waite, OVP Venture Partners |
|
Chad Waite joined OVP Venture Partners in 1987 and focuses on investments in the digital biology, and network security sectors. His investments include 4thPass, Accelerator, Adapx, Airgo Networks, Altus, Boston Beer, Cardima, CellPro, CODA Genomics, Complete Genomics, Corixa, Serengeti, Etera, Filenet, GenoLogics, GreaterGood.com, Loudeye Technologies, NanoString, Plectix BioSystems, ProTools, Quantum Medical, Raytel Medical, Returns Online, Rosetta Inpharmatics, SafeHarbor, Saros, Seattle Genetics, SignalSoft, Syntellect, Vantos, Verity, and WatchGuard.
|
|
More...
|
|
|
|
